Patrick Jean‐Philippe

5.1k total citations · 1 hit paper
61 papers, 2.9k citations indexed

About

Patrick Jean‐Philippe is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Patrick Jean‐Philippe has authored 61 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Infectious Diseases, 27 papers in Epidemiology and 24 papers in Virology. Recurrent topics in Patrick Jean‐Philippe's work include HIV/AIDS Research and Interventions (30 papers), HIV Research and Treatment (24 papers) and HIV/AIDS drug development and treatment (24 papers). Patrick Jean‐Philippe is often cited by papers focused on HIV/AIDS Research and Interventions (30 papers), HIV Research and Treatment (24 papers) and HIV/AIDS drug development and treatment (24 papers). Patrick Jean‐Philippe collaborates with scholars based in United States, South Africa and Zimbabwe. Patrick Jean‐Philippe's co-authors include Avy Violari, Shabir A. Madhi, Diana M. Gibb, James McIntyre, Jan Steyn, Abdel G. Babiker, Mark F. Cotton, Mark F. Cotton, Sharon Nachman and Raziya Bobat and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PEDIATRICS.

In The Last Decade

Patrick Jean‐Philippe

57 papers receiving 2.9k citations

Hit Papers

Early Antiretroviral Therapy and Mortality among HIV-Infe... 2008 2026 2014 2020 2008 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Jean‐Philippe United States 22 2.3k 1.2k 1.1k 544 295 61 2.9k
Thanyawee Puthanakit Thailand 30 2.0k 0.9× 991 0.8× 843 0.8× 615 1.1× 282 1.0× 163 2.8k
Avy Violari South Africa 30 2.8k 1.2× 1.4k 1.2× 1.6k 1.5× 660 1.2× 547 1.9× 122 4.1k
Ashraf Coovadia South Africa 34 1.9k 0.8× 1.2k 1.0× 565 0.5× 805 1.5× 420 1.4× 114 2.8k
Helena Rabie South Africa 28 2.0k 0.9× 602 0.5× 1.1k 1.0× 351 0.6× 306 1.0× 176 2.9k
Joseph Makhema United States 28 1.9k 0.8× 808 0.6× 818 0.8× 564 1.0× 342 1.2× 147 2.7k
Mark F. Cotton South Africa 16 1.6k 0.7× 733 0.6× 776 0.7× 312 0.6× 259 0.9× 42 1.9k
Edward Handelsman United States 21 2.3k 1.0× 1.2k 1.0× 1.1k 1.1× 700 1.3× 424 1.4× 29 2.9k
Willy Were Uganda 24 2.1k 0.9× 734 0.6× 1.2k 1.1× 354 0.7× 479 1.6× 31 2.6k
Isaac Zulu Zambia 26 2.0k 0.9× 728 0.6× 876 0.8× 402 0.7× 750 2.5× 51 2.7k
Rohan Hazra United States 39 2.7k 1.2× 1.1k 0.9× 1.1k 1.0× 1.5k 2.8× 493 1.7× 134 4.1k

Countries citing papers authored by Patrick Jean‐Philippe

Since Specialization
Citations

This map shows the geographic impact of Patrick Jean‐Philippe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Jean‐Philippe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Jean‐Philippe more than expected).

Fields of papers citing papers by Patrick Jean‐Philippe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Jean‐Philippe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Jean‐Philippe. The network helps show where Patrick Jean‐Philippe may publish in the future.

Co-authorship network of co-authors of Patrick Jean‐Philippe

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Jean‐Philippe. A scholar is included among the top collaborators of Patrick Jean‐Philippe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Jean‐Philippe. Patrick Jean‐Philippe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ajibola, Gbolahan, Michael D. Hughes, Dwight E. Yin, et al.. (2025). Long-Term Clinical, Immunologic, and Viral Reservoir Outcomes in Children Treated With VRC01LS and 10-1074 Monoclonal Antibodies in the Tatelo Study. Clinical Infectious Diseases. 82(2). e278–e285.
3.
Garcia‐Prats, Anthony J., Graeme Hoddinott, Pauline Howell, et al.. (2023). Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis. The Lancet Infectious Diseases. 23(7). 778–780. 5 indexed citations
4.
Tierney, Camlin, Deborah Persaud, Jennifer Jao, et al.. (2022). Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life. Clinical Infectious Diseases. 76(3). e744–e747. 2 indexed citations
5.
Fairlie, Lee, Miriam Chernoff, Mark F. Cotton, et al.. (2022). Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa. Frontiers in Pediatrics. 10. 899002–899002. 1 indexed citations
6.
Jain, Sanjay K., Savvas Andronikou, Pierre Goussard, et al.. (2020). Advanced imaging tools for childhood tuberculosis: potential applications and research needs. The Lancet Infectious Diseases. 20(11). e289–e297. 25 indexed citations
7.
PrabhuDas, Mercy, Jeanna Piper, Patrick Jean‐Philippe, & Marrah E. Lachowicz-Scroggins. (2020). Immune Regulation, Maternal Infection, Vaccination, and Pregnancy Outcome. Journal of Women s Health. 30(2). 199–206. 14 indexed citations
8.
García‐Broncano, Pilar, Kevin Einkauf, Chenyang Jiang, et al.. (2019). Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile. Science Translational Medicine. 11(520). 72 indexed citations
10.
Jean‐Philippe, Patrick, Hans Spiegel, Devasena Gnanashanmugam, et al.. (2017). HIV birth testing and linkage to care for HIV-infected infants. AIDS. 31(13). 1797–1807. 11 indexed citations
11.
Hué, Stéphane, Avy Violari, Mark F. Cotton, et al.. (2015). Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(2). 138–144. 8 indexed citations
13.
14.
Violari, Avy, Jane C. Lindsey, Michael D. Hughes, et al.. (2012). Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children. New England Journal of Medicine. 366(25). 2380–2389. 150 indexed citations
15.
Laughton, Barbara, Morna Cornell, D Grové, et al.. (2012). Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS. 26(13). 1685–1690. 135 indexed citations
16.
Siberry, George K., Meredith G. Warshaw, Paige L. Williams, et al.. (2011). Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in 2- to 10-year-old Human Immunodeficiency Virus-infected Children. The Pediatric Infectious Disease Journal. 31(1). 47–52. 28 indexed citations
17.
Madhi, Shabir A., Sharon Nachman, Avy Violari, et al.. (2011). Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed Children. New England Journal of Medicine. 365(1). 21–31. 118 indexed citations
18.
Madhi, Shabir A., Peter V. Adrian, Mark F. Cotton, et al.. (2010). Effect of HIV Infection Status and Anti‐Retroviral Treatment on Quantitative and Qualitative Antibody Responses to Pneumococcal Conjugate Vaccine in Infants. The Journal of Infectious Diseases. 202(3). 355–361. 83 indexed citations
19.
Palumbo, Paul, Jane C. Lindsey, Michael D. Hughes, et al.. (2010). Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure. New England Journal of Medicine. 363(16). 1510–1520. 172 indexed citations
20.
King, Jennifer R., Edward P. Acosta, Ram Yogev, et al.. (2009). STEADY-STATE PHARMACOKINETICS OF LOPINAVIR/RITONAVIR IN COMBINATION WITH EFAVIRENZ IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTS. The Pediatric Infectious Disease Journal. 28(2). 159–161. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026